Agomab Therapeutics AGMB Balance Sheet (2024-2025)

NASDAQ AGMB
$13.25 -0.18 (-1.34%)
As of: Aug 21, 2026 · 10:12 AM EDT
1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2024 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter) 183.22M100.59M
Short-term Investments (Quarter) 35.03M
Cash & Current Investments (Quarter) 183.22M135.63M
Receivables (Quarter) 3.35M7.14M
Prepaid Assets (Quarter) 2.55M5.50M
Current Assets (Quarter) 185.77M141.13M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 34.74M37.80M
Goodwill (Quarter) 9.20M10.02M
Intangibles (Quarter) 21.49M23.41M
Goodwill & Intangibles (Quarter) 30.69M33.43M
Other Non-Current Assets (Quarter) 0.01M0.01M
Non-Current Assets (Quarter) 34.74M37.80M
Assets (Quarter) 220.51M178.92M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 8.60M11.95M
Payables (Quarter) 8.60M11.95M
Accumulated Expenses (Quarter) 2.05M2.76M
Short term Debt (Quarter) 7.60M
Current Leases (Quarter) 0.29M0.29M
Current Deferred Revenue (Quarter) 0.86M1.70M
Curent Deferred Tax Liability (Quarter) 0.86M1.80M
Total Current Liabilities (Quarter) 9.75M21.64M
Non-Current Liabilities
Operating Leases (Quarter) 1.36M1.17M
Other Non-Current Liabilities (Quarter) 8.42M3.74M
Total Non-Current Liabilities (Quarter) 9.78M4.91M
Total Liabilities (Quarter) 19.53M26.54M
Shareholder's Equity
Total Debt (Quarter) 7.60M
Common Equity (Quarter) 200.98M152.38M
Liabilities and Shareholders Equity (Quarter) 220.51M178.92M
Retained Earnings (Quarter) -1.03M-1.13M